261 related articles for article (PubMed ID: 26867569)
1. Analysis of mitochondrial DNA alteration in new phenotype ACOS.
Carpagnano GE; Lacedonia D; Malerba M; Palmiotti GA; Cotugno G; Carone M; Foschino-Barbaro MP
BMC Pulm Med; 2016 Feb; 16():31. PubMed ID: 26867569
[TBL] [Abstract][Full Text] [Related]
2. Study of mitochondrial DNA alteration in the exhaled breath condensate of patients affected by obstructive lung diseases.
Carpagnano GE; Lacedonia D; Carone M; Soccio P; Cotugno G; Palmiotti GA; Scioscia G; Foschino Barbaro MP
J Breath Res; 2016 Apr; 10(2):026005. PubMed ID: 27063576
[TBL] [Abstract][Full Text] [Related]
3. Expression profiling of miRNA-145 and miRNA-338 in serum and sputum of patients with COPD, asthma, and asthma-COPD overlap syndrome phenotype.
Lacedonia D; Palladino GP; Foschino-Barbaro MP; Scioscia G; Carpagnano GE
Int J Chron Obstruct Pulmon Dis; 2017; 12():1811-1817. PubMed ID: 28694694
[TBL] [Abstract][Full Text] [Related]
4. Relationship between Fractional Exhaled Nitric Oxide Level and Efficacy of Inhaled Corticosteroid in Asthma-COPD Overlap Syndrome Patients with Different Disease Severity.
Feng JX; Lin Y; Lin J; He SS; Chen MF; Wu XM; Xu YZ
J Korean Med Sci; 2017 Mar; 32(3):439-447. PubMed ID: 28145647
[TBL] [Abstract][Full Text] [Related]
5. Asthma-COPD Overlap Syndrome (ACOS): Single disease entity or not? Could exhaled nitric oxide be a useful biomarker for the differentiation of ACOS, asthma and COPD?
Karampitsakos T; Gourgoulianis KI
Med Hypotheses; 2016 Jun; 91():20-23. PubMed ID: 27142135
[TBL] [Abstract][Full Text] [Related]
6. Is a previous diagnosis of asthma a reliable criterion for asthma-COPD overlap syndrome in a patient with COPD?
Barrecheguren M; Román-Rodríguez M; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2015; 10():1745-52. PubMed ID: 26366067
[TBL] [Abstract][Full Text] [Related]
7. Searching for Inflammatory and Oxidative Stress Markers Capable of Clustering Severe Asthma.
Carpagnano GE; Scioscia G; Lacedonia D; Soccio P; Quarato CMI; Cotugno G; Palumbo MG; Foschino Barbaro MP
Arch Bronconeumol (Engl Ed); 2021 May; 57(5):338-344. PubMed ID: 32593535
[TBL] [Abstract][Full Text] [Related]
8. Asthma-COPD overlap syndrome (ACOS) vs 'pure' COPD: a distinct phenotype?
Caillaud D; Chanez P; Escamilla R; Burgel PR; Court-Fortune I; Nesme-Meyer P; Deslee G; Perez T; Paillasseur JL; Pinet C; Jebrak G; Roche N;
Allergy; 2017 Jan; 72(1):137-145. PubMed ID: 27501862
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial DNA alteration in obstructive sleep apnea.
Lacedonia D; Carpagnano GE; Crisetti E; Cotugno G; Palladino GP; Patricelli G; Sabato R; Foschino Barbaro MP
Respir Res; 2015 Apr; 16(1):47. PubMed ID: 25890226
[TBL] [Abstract][Full Text] [Related]
10. Blurred lines. Eosinophilic COPD: ACOS or COPD phenotype?
Loureiro CC
Rev Port Pneumol (2006); 2016; 22(5):279-82. PubMed ID: 27013320
[TBL] [Abstract][Full Text] [Related]
11. Characterization of sputum biomarkers for asthma-COPD overlap syndrome.
Gao J; Iwamoto H; Koskela J; Alenius H; Hattori N; Kohno N; Laitinen T; Mazur W; Pulkkinen V
Int J Chron Obstruct Pulmon Dis; 2016; 11():2457-2465. PubMed ID: 27757028
[TBL] [Abstract][Full Text] [Related]
12. Value of Exhaled Nitric Oxide (FeNO) And Eosinophilia During the Exacerbations of Chronic Obstructive Pulmonary Disease Requiring Hospital Admission.
Río Ramírez MT; Juretschke Moragues MA; Fernández González R; Álvarez Rodríguez V; Aznar Andrés E; Zabaleta Camino JP; Romero Pareja R; Esteban de la Torre A
COPD; 2018; 15(4):369-376. PubMed ID: 30064275
[TBL] [Abstract][Full Text] [Related]
13. What pulmonologists think about the asthma-COPD overlap syndrome.
Miravitlles M; Alcázar B; Alvarez FJ; Bazús T; Calle M; Casanova C; Cisneros C; de-Torres JP; Entrenas LM; Esteban C; García-Sidro P; Cosio BG; Huerta A; Iriberri M; Izquierdo JL; López-Viña A; López-Campos JL; Martínez-Moragón E; Pérez de Llano L; Perpiñá M; Ros JA; Serrano J; Soler-Cataluña JJ; Torrego A; Urrutia I; Plaza V
Int J Chron Obstruct Pulmon Dis; 2015; 10():1321-30. PubMed ID: 26270415
[TBL] [Abstract][Full Text] [Related]
14. Biomarker-based detection of asthma-COPD overlap syndrome in COPD populations.
Tamada T; Sugiura H; Takahashi T; Matsunaga K; Kimura K; Katsumata U; Takekoshi D; Kikuchi T; Ohta K; Ichinose M
Int J Chron Obstruct Pulmon Dis; 2015; 10():2169-76. PubMed ID: 26491283
[TBL] [Abstract][Full Text] [Related]
15. The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges.
Barrecheguren M; Esquinas C; Miravitlles M
Curr Opin Pulm Med; 2015 Jan; 21(1):74-9. PubMed ID: 25405671
[TBL] [Abstract][Full Text] [Related]
16. Clinical, physiological, and radiological features of asthma-chronic obstructive pulmonary disease overlap syndrome.
Suzuki T; Tada Y; Kawata N; Matsuura Y; Ikari J; Kasahara Y; Tatsumi K
Int J Chron Obstruct Pulmon Dis; 2015; 10():947-54. PubMed ID: 26028967
[TBL] [Abstract][Full Text] [Related]
17. [Asthma-COPD overlap syndrome (ACOS)].
Takiguchi H; Asano K
Nihon Rinsho; 2016 May; 74(5):778-82. PubMed ID: 27254946
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the efficacy of once-daily fluticasone furoate/vilanterole with twice-daily fluticasone propionate/salmeterol in asthma-COPD overlap syndrome.
Ishiura Y; Fujimura M; Shiba Y; Ohkura N; Hara J; Kasahara K
Pulm Pharmacol Ther; 2015 Dec; 35():28-33. PubMed ID: 26497109
[TBL] [Abstract][Full Text] [Related]
19. Different prevalence and clinical characteristics of asthma-chronic obstructive pulmonary disease overlap syndrome according to accepted criteria.
Jo YS; Lee J; Yoon HI; Kim DK; Yoo CG; Lee CH
Ann Allergy Asthma Immunol; 2017 Jun; 118(6):696-703.e1. PubMed ID: 28583262
[TBL] [Abstract][Full Text] [Related]
20. Cell-free DNA levels associate with COPD exacerbations and mortality.
Ware SA; Kliment CR; Giordano L; Redding KM; Rumsey WL; Bates S; Zhang Y; Sciurba FC; Nouraie SM; Kaufman BA
Respir Res; 2024 Jan; 25(1):42. PubMed ID: 38238743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
